Hunt JT - Search Results

1

1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil.

Kimball SD, Hunt JT, Barrish JC, Das J, Floyd DM, Lago MW, Lee VG, Spergel SH, Moreland S, Hedberg SA, et al. Kimball SD, et al. Among authors: hunt jt. Bioorg Med Chem. 1993 Oct;1(4):285-307. doi: 10.1016/s0968-0896(00)82134-3. Bioorg Med Chem. 1993. PMID: 8081860

2

Site-specific biotinylation. A novel approach and its application to endothelin-1 analogs and PTH-analog.

Natarajan S, Festin SM, Hedberg A, Liu EC, Floyd DM, Hunt JT. Natarajan S, et al. Among authors: hunt jt. Int J Pept Protein Res. 1992 Dec;40(6):567-74. Int J Pept Protein Res. 1992. PMID: 1286942

3

Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.

Kimball SD, Floyd DM, Das J, Hunt JT, Krapcho J, Rovnyak G, Duff KJ, Lee VG, Moquin RV, Turk CF, et al. Kimball SD, et al. Among authors: hunt jt. J Med Chem. 1992 Feb 21;35(4):780-93. doi: 10.1021/jm00082a020. J Med Chem. 1992. PMID: 1311765

4

Venous smooth muscle contains vasoconstrictor ETB-like receptors.

Moreland S, McMullen DM, Delaney CL, Lee VG, Hunt JT. Moreland S, et al. Among authors: hunt jt. Biochem Biophys Res Commun. 1992 Apr 15;184(1):100-6. doi: 10.1016/0006-291x(92)91163-k. Biochem Biophys Res Commun. 1992. PMID: 1314581

5

Peptide analogs of the pseudosubstrate domain of smooth muscle myosin light chain kinase inhibit actomyosin ATPase activity at concentrations that do not inhibit superprecipitation.

Moreland S, Ikebe M, Hunt JT, Moreland RS. Moreland S, et al. Among authors: hunt jt. Biochem Biophys Res Commun. 1992 Sep 30;187(3):1279-84. doi: 10.1016/0006-291x(92)90441-m. Biochem Biophys Res Commun. 1992. PMID: 1417804

6

Substrate based inhibitors of smooth muscle myosin light chain kinase.

Moreland S, Ikebe M, Hunt JT, Moreland RS. Moreland S, et al. Among authors: hunt jt. Biochem Biophys Res Commun. 1992 May 29;185(1):379-85. doi: 10.1016/s0006-291x(05)80996-9. Biochem Biophys Res Commun. 1992. PMID: 1599475

7

Minimum requirements for inhibition of smooth-muscle myosin light-chain kinase by synthetic peptides.

Hunt JT, Floyd DM, Lee VG, Little DK, Moreland S. Hunt JT, et al. Biochem J. 1989 Jan 1;257(1):73-8. doi: 10.1042/bj2570073. Biochem J. 1989. PMID: 2920029 Free PMC article.

8

Hydroxyamino acid specificity of smooth muscle myosin light chain kinase.

Pearson RB, Floyd DM, Hunt JT, Lee VG, Kemp BE. Pearson RB, et al. Among authors: hunt jt. Arch Biochem Biophys. 1988 Jan;260(1):37-44. doi: 10.1016/0003-9861(88)90421-3. Arch Biochem Biophys. 1988. PMID: 3341750

9

The receptor binding affinity of monocyclic [Ala3,Xaa11]endothelin-1 analogs correlates with inducible helix length.

Andersen NH, Harris SM, Lee VG, Liu EC, Moreland S, Hunt JT. Andersen NH, et al. Among authors: hunt jt. Bioorg Med Chem. 1995 Feb;3(2):113-24. doi: 10.1016/0968-0896(95)00005-2. Bioorg Med Chem. 1995. PMID: 7796045

10

Three-dimensional quantitative structure-activity relationships of sulfonamide endothelin inhibitors.

Krystek SR Jr, Hunt JT, Stein PD, Stouch TR. Krystek SR Jr, et al. Among authors: hunt jt. J Med Chem. 1995 Feb 17;38(4):659-68. doi: 10.1021/jm00004a012. J Med Chem. 1995. PMID: 7861414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters